How do bundled payment models affect hospital purchasing decisions for SSI prevention products?

Bundled payments reward infection-free surgical episodes with bonus payments, making advanced SSI prevention consumables a direct revenue investment rather than a cost center. Hospitals under CMS BPCI-A report 12–18% higher spending on antimicrobial products per surgical case [2]. Read More

Which antimicrobial suture coating technology shows the strongest clinical evidence for SSI reduction?

Triclosan-coated polyglactin (VICRYL Plus) has the broadest clinical trial base, with meta-analyses showing a 30% relative reduction in SSI incidence across abdominal and orthopedic procedures [11]. Read More

How does negative-pressure wound therapy compare to standard dressings in high-risk surgeries?

Negative-pressure systems reduce SSI rates by 40–50% in obese patients and revision surgeries compared to conventional gauze dressings, though device costs limit adoption in budget-constrained facilities [14]. Read More

What role do infection preventionists play in surgical site infection control procurement decisions?

Infection preventionists directly influence product selection, protocol design, and compliance auditing, making them primary decision-makers alongside surgeons and supply-chain managers in most acute-care settings [16]. Read More

How are antimicrobial resistance patterns shaping the Surgical Site Infection Control Market product pipeline?

Rising MRSA and gram-negative resistance is shifting R&D toward non-antibiotic approaches including bacteriophage-coated dressings, silver nanoparticle technologies, and microbiome-sparing antiseptics [15]. Read More

What integration challenges exist when deploying AI-based SSI surveillance in the Surgical Site Infection Control Market?

Primary barriers include EHR interoperability gaps, inconsistent wound-classification coding, and clinician trust deficits — most pilots require 6–12 months of parallel manual validation before full deployment [10]. Read More

How do ambulatory surgical centers approach the Surgical Site Infection Control Market differently from hospitals?

ASCs prioritize compact, pre-packaged single-use kits that minimize storage and sterilization infrastructure, favoring bundled surgical prep solutions over component-level purchasing [13]. Read More

Surgical Site Infection Control Market

ID: MRFR/MED/6359-HCR

200 Pages

Vikita Thakur

Last Updated: June 22, 2026

Surgical Site Infection Control Market Research Report By Product Type (Disinfectants, Antiseptics, Surgical Drapes, Surgical Gloves), By End User (Hospitals, Ambulatory Surgical Centers, Clinics), By Infection Control Method (Preoperative, Intraoperative, Postoperative), By Formulation (Liquids, Gels, Sprays) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 Market Overview |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology
2 Market Summary & Key Takeaways
3 Market Dynamics |
1. 3.1 Market Drivers Analysis | |
  1. 3.1.1 Rising Global Surgical Volumes | |
  2. 3.1.2 Regulatory HAI Penalty Programs | |
  3. 3.1.3 Aging Population and Comorbidity Burden | |
  4. 3.1.4 Hospital Infrastructure Expansion in Emerging Markets | |
  5. 3.1.5 Adoption of AI-Enabled Infection Surveillance | |
  6. 3.1.6 Growth in Ambulatory Surgical Center Volumes | |
  7. 3.1.7 Perioperative Antibiotic Prophylaxis Guideline Updates |
2. 3.2 Market Restraints Analysis | |
  1. 3.2.1 High Cost of Advanced Infection-Control Technologies | |
  2. 3.2.2 Antimicrobial Resistance Undermining Existing Protocols | |
  3. 3.2.3 Shortage of Trained Infection-Control Professionals | |
  4. 3.2.4 Slow Adoption of Digital Surveillance in LMICs | |
  5. 3.2.5 Reimbursement Variability Across Geographies |
3. 3.3 Market Opportunity Analysis | |
  1. 3.3.1 AI-Enabled Real-Time SSI Surveillance Platforms | |
  2. 3.3.2 Single-Use Surgical Draping and Gowning Systems | |
  3. 3.3.3 Emerging-Market Infection-Control Bundling Programs | |
  4. 3.3.4 Data Monetization Through Infection-Outcome Analytics | |
  5. 3.3.5 Antimicrobial Coating Innovation for Implantable Devices |
4. 3.4 Industry Value Chain Analysis |
5. 3.5 Porter's Five Forces Analysis
4 Global Surgical Site Infection Control Market Size & Forecast (2021–2035) |
1. 4.1 Historical Market Size (2021–2025) |
2. 4.2 Current & Forecast Market Size (2026–2035) |
3. 4.3 Market Size by Revenue (USD Billion) |
4. 4.4 Year-over-Year Growth Analysis
5 Segmentation Analysis |
1. 5.1 By Product | |
  1. 5.1.1 Disinfectants | |
  2. 5.1.2 Manual Reprocessors Solution | |
  3. 5.1.3 Antimicrobial Sutures | |
  4. 5.1.4 Surgical Drapes & Gowns | |
  5. 5.1.5 Wound-Care Devices | |
  6. 5.1.6 Others |
2. 5.2 By Surgery/Procedure | |
  1. 5.2.1 Cesarean Section | |
  2. 5.2.2 Orthopedic Surgery | |
  3. 5.2.3 Cataract Surgery | |
  4. 5.2.4 Colorectal Surgery | |
  5. 5.2.5 Cardiac Surgery | |
  6. 5.2.6 Others |
3. 5.3 By Type of Infection | |
  1. 5.3.1 Superficial Incisional SSI | |
  2. 5.3.2 Deep Incisional SSI | |
  3. 5.3.3 Organ/Space SSI |
4. 5.4 By End-User | |
  1. 5.4.1 Hospitals | |
  2. 5.4.2 Ambulatory Surgical Centers | |
  3. 5.4.3 Clinics & Others
6 Regional Analysis |
1. 6.1 North America | |
  1. 6.1.1 United States | |
  2. 6.1.2 Canada | |
  3. 6.1.3 Mexico |
2. 6.2 Europe | |
  1. 6.2.1 Germany | |
  2. 6.2.2 United Kingdom | |
  3. 6.2.3 France | |
  4. 6.2.4 Italy | |
  5. 6.2.5 Spain | |
  6. 6.2.6 Nordic Countries | |
  7. 6.2.7 Russia | |
  8. 6.2.8 Rest of Europe |
3. 6.3 Asia-Pacific | |
  1. 6.3.1 China | |
  2. 6.3.2 India | |
  3. 6.3.3 Japan | |
  4. 6.3.4 South Korea | |
  5. 6.3.5 ASEAN | |
  6. 6.3.6 Rest of Asia-Pacific |
4. 6.4 South America | |
  1. 6.4.1 Brazil | |
  2. 6.4.2 Argentina | |
  3. 6.4.3 Rest of South America |
5. 6.5 Middle East & Africa | |
  1. 6.5.1 Saudi Arabia | |
  2. 6.5.2 UAE | |
  3. 6.5.3 South Africa | |
  4. 6.5.4 Egypt | |
  5. 6.5.5 Rest of MEA
7 Competitive Landscape |
1. 7.1 Market Share Analysis (2025) |
2. 7.2 Competitive Benchmarking Matrix |
3. 7.3 Company Profiles | |
  1. 7.3.1 3M Healthcare | |
  2. 7.3.2 BD (Becton Dickinson) | |
  3. 7.3.3 Johnson & Johnson (Ethicon) | |
  4. 7.3.4 Mölnlycke Health Care | |
  5. 7.3.5 STERIS plc | |
  6. 7.3.6 Getinge AB | |
  7. 7.3.7 B. Braun Melsungen | |
  8. 7.3.8 Cardinal Health | |
  9. 7.3.9 Medline Industries | |
  10. 7.3.10 PDI Healthcare
8 Future Outlook & Strategic Recommendations (2026–2035) |
1. 8.1 AI and Predictive Analytics in Infection Prevention |
2. 8.2 Antimicrobial Stewardship and Resistance Management |
3. 8.3 Value-Based Care and Outcome-Linked Procurement |
4. 8.4 Decentralization of Surgical Care to Ambulatory Settings
9 Recent Developments & News
10 Frequently Asked Questions (FAQs)
11 Report Scope & Methodology |
1. 11.1 Study Period & Base Year |
2. 11.2 Data Sources & Citations |
3. 11.3 Abbreviations
12 LIST OF TABLES |
TABLE 1 Global Surgical Site Infection Control Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
TABLE 2 Global Surgical Site Infection Control Market — Year-over-Year Growth Analysis, 2021–2035 |
TABLE 3 Driver Impact Analysis — Surgical Site Infection Control Market |
TABLE 4 Restraint Impact Analysis — Surgical Site Infection Control Market |
TABLE 5 Regional Market Share Summary — Surgical Site Infection Control Market, 2025 |
TABLE 6 North America Surgical Site Infection Control Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 7 Europe Surgical Site Infection Control Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 8 Asia-Pacific Surgical Site Infection Control Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 9 South America Surgical Site Infection Control Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 10 Middle East & Africa Surgical Site Infection Control Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 11 Global Surgical Site Infection Control Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 12 Global Surgical Site Infection Control Market Size, by Surgery/Procedure, 2021–2035 (USD Billion) |
TABLE 13 Global Surgical Site Infection Control Market Size, by Type of Infection, 2021–2035 (USD Billion) |
TABLE 14 Global Surgical Site Infection Control Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 15 Competitive Benchmarking Matrix — Surgical Site Infection Control Market, 2025 |
TABLE 16 Company Profiles — Key Players, Surgical Site Infection Control Market |
TABLE 17 Recent Developments & Strategic Announcements, 2023–2025 |
TABLE 18 North America Surgical Site Infection Control Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 19 North America Surgical Site Infection Control Market Size, by Surgery/Procedure, 2021–2035 (USD Billion) |
TABLE 20 North America Surgical Site Infection Control Market Size, by Type of Infection, 2021–2035 (USD Billion) |
TABLE 21 North America Surgical Site Infection Control Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 22 Europe Surgical Site Infection Control Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 23 Europe Surgical Site Infection Control Market Size, by Surgery/Procedure, 2021–2035 (USD Billion) |
TABLE 24 Europe Surgical Site Infection Control Market Size, by Type of Infection, 2021–2035 (USD Billion) |
TABLE 25 Europe Surgical Site Infection Control Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 26 Asia-Pacific Surgical Site Infection Control Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 27 Asia-Pacific Surgical Site Infection Control Market Size, by Surgery/Procedure, 2021–2035 (USD Billion) |
TABLE 28 Asia-Pacific Surgical Site Infection Control Market Size, by Type of Infection, 2021–2035 (USD Billion) |
TABLE 29 Asia-Pacific Surgical Site Infection Control Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 30 South America Surgical Site Infection Control Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 31 South America Surgical Site Infection Control Market Size, by Surgery/Procedure, 2021–2035 (USD Billion) |
TABLE 32 South America Surgical Site Infection Control Market Size, by Type of Infection, 2021–2035 (USD Billion) |
TABLE 33 South America Surgical Site Infection Control Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 34 Middle East & Africa Surgical Site Infection Control Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 35 Middle East & Africa Surgical Site Infection Control Market Size, by Surgery/Procedure, 2021–2035 (USD Billion) |
TABLE 36 Middle East & Africa Surgical Site Infection Control Market Size, by Type of Infection, 2021–2035 (USD Billion) |
TABLE 37 Middle East & Africa Surgical Site Infection Control Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 38 Report Scope & Methodology Summary |
TABLE 39 Detailed Sources and Citations
13 LIST OF FIGURES |
FIGURE 1 Surgical Site Infection Control Market Dynamics — Drivers, Restraints, and Opportunities |
FIGURE 2 Industry Value Chain Analysis — Surgical Site Infection Control Market |
FIGURE 3 Porter's Five Forces Analysis — Surgical Site Infection Control Market |
FIGURE 4 Global Surgical Site Infection Control Market Size Trend (USD Billion), 2021–2035 |
FIGURE 5 Surgical Site Infection Control Market Share, by Product, 2025 |
FIGURE 6 Surgical Site Infection Control Market Share, by Surgery/Procedure, 2025 |
FIGURE 7 Surgical Site Infection Control Market Share, by Type of Infection, 2025 |
FIGURE 8 Surgical Site Infection Control Market Share, by End-User, 2025 |
FIGURE 9 Surgical Site Infection Control Market Share, by Region, 2025 |
FIGURE 10 North America Surgical Site Infection Control Market Size (USD Billion), 2021–2035 |
FIGURE 11 Europe Surgical Site Infection Control Market Size (USD Billion), 2021–2035 |
FIGURE 12 Asia-Pacific Surgical Site Infection Control Market Size (USD Billion), 2021–2035 |
FIGURE 13 South America Surgical Site Infection Control Market Size (USD Billion), 2021–2035 |
FIGURE 14 Middle East & Africa Surgical Site Infection Control Market Size (USD Billion), 2021–2035 |
FIGURE 15 Competitive Landscape — Market Share Analysis, 2025

Certified Researchers

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
By Product	Disinfectants, Manual Reprocessors Solution, Antimicrobial Sutures, Surgical Drapes & Gowns, Wound-Care Devices, Others	Disinfectants	Wound-Care Devices
By Surgery/Procedure	Cesarean Section, Orthopedic Surgery, Cataract Surgery, Colorectal Surgery, Cardiac Surgery, Others	Cesarean Section	Orthopedic Surgery
By Type of Infection	Superficial Incisional SSI, Deep Incisional SSI, Organ/Space SSI	Superficial Incisional SSI	Deep Incisional SSI
By End-User	Hospitals, Ambulatory Surgical Centers, Clinics & Others	Hospitals	Ambulatory Surgical Centers
By Geography	North America, Europe, Asia-Pacific, South America, Middle East & Africa	North America	Asia-Pacific

Market Segmentation Overview

By Product

Sub-Segment	Key Trend
Disinfectants	Shift toward hydrogen peroxide vapor and extended-residual formulations
Manual Reprocessors Solution	Cost-effective adoption in ambulatory and resource-limited settings
Antimicrobial Sutures	Triclosan-coated sutures becoming standard-of-care in high-risk closures
Surgical Drapes & Gowns	Migration from reusable to single-use systems with antimicrobial barriers
Wound-Care Devices	Negative-pressure wound therapy driving premium device adoption
Others	Emerging technologies including antimicrobial coatings and biofilm disruptors

The product segmentation reflects a market in transition from commodity disinfectants toward integrated, technology-enhanced infection-prevention systems that combine surgical wound antisepsis, environmental decontamination, and post-operative monitoring.

By Surgery/Procedure

Sub-Segment	Key Trend
Cesarean Section	Standardized perioperative antibiotic prophylaxis bundles driving consumable demand
Orthopedic Surgery	Prosthetic-joint infection prevention fueling premium product uptake
Cataract Surgery	High outpatient volume sustaining steady antiseptic consumable sales
Colorectal Surgery	Elevated SSI rates (10–15%) necessitating multi-layered prevention protocols
Cardiac Surgery	Mediastinitis prevention driving adoption of advanced wound closure solutions
Others	General, urological, and vascular procedures contributing incremental demand

Procedure-level SSI risk varies dramatically — from under 1% in cataract surgery to over 10% in colorectal operations — shaping highly differentiated product requirements across surgical specialties.

By Type of Infection

Sub-Segment	Key Trend
Superficial Incisional SSI	Most frequently reported category; primary target for skin-prep and draping products
Deep Incisional SSI	Rising with implant volume; drives demand for antimicrobial sutures and coatings
Organ/Space SSI	Highest cost and mortality burden; focus of advanced surveillance and wound-care devices

Infection depth directly correlates with clinical severity and cost, with organ/space SSIs costing healthcare systems 3–5 times more than superficial infections per episode.

By End-User

Sub-Segment	Key Trend
Hospitals	Broadest product portfolio demand; regulatory compliance driving upgrades
Ambulatory Surgical Centers	Fastest-growing channel; pre-packaged kit preference reshaping distribution
Clinics & Others	Minor surgical procedures sustaining baseline antiseptic consumable demand

The end-user landscape is evolving as surgical care decentralizes from large hospitals into ambulatory and outpatient settings, requiring manufacturers to adapt packaging, pricing, and distribution strategies for smaller-volume, higher-frequency procurement cycles.

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”